E. Legouffe et al., C-reactive protein serum level is a valuable and simple prognostic marker in norm Hodgkin's lymphoma, LEUK LYMPH, 31(3-4), 1998, pp. 351-357
Interleukin-6 plays a central role in normal B-cell maturation and in proli
feration of some B-cell malignancies including multiple myeloma and some no
n Hodgkin's lymphomas (NHL). Furthermore, this cytokine also plays a major
role in acute phase response by mediating synthesis of acute phase proteins
such as C-reactive protein (CRP). In order to evaluate the exact role of C
RP serum level as a simple prognostic factor, we analyzed CRP and IL-6 seru
m levels in 39 patients with NHL. Eleven patients had low grade NHL, 15 int
ermediate grade NHL, and 13 high grade NHL. Thirty percent of the patients
presented detectable IL-6 serum levels (mean +/- SD: 33.6 +/- 95.2 U/ml, ra
nge: 0 to 500). Increased serum CRP levels were found in 42% of the patient
s with a mean of 29.2 +/- 41.97 mg/l (range: 0 to 129).
Thirty seven patients were studied for both markers. Three groups of patien
ts were determined. One with low IL-6 and CRP serum levels (N=21), a second
with high level of both markers (N=10), and the third with high serum CRP
levels alone (N=5). Only one patient had high level of serum IL-6 with no d
etectable CRP. The correlation of serum IL-6 and CRP levels with patient su
rvival was investigated. Median survival in the group with low IL-6 level w
as not reached. 67% of patients of this group were still alive at 32 months
from diagnosis. The group of patients with detectable IL-6 had a median of
survival of 12 months (p<0.025). The survival of patients with a CRP<10 mg
/l was not reached. 75% of patients survive at 32 months from diagnosis, wh
ereas the group with higher CRP level reached a median survival at 8.5 mont
hs (p<0.009). As expected, on univariate analysis, there is a significant r
elationship between CRP and IL-6 levels (p<0.00017), and CRP levels and B s
ymptoms (p<0.001). Furthermore there is a significant relationship between
CRP and LDH levels (p<0.042). These results indicated that CRP may be consi
dered as a valuable and easy prognostic biomarker of NHL.